The Israeli Ministry of Health has announced that the protection of the BioNTech vaccine has decreased to 64%.
According to the statement made by the Ministry of Health, the effectiveness of the vaccine in preventing the spread of the disease and symptomatic cases decreased to 64% as of 6 June.
It was announced that the vaccine was 93% effective in preventing hospitalizations and severe cases.
According to the study published in the Lancet journal in May, it was announced that the BioNTech vaccine was 97% more effective in preventing the spread of corona virus, symptomatic and severe cases after 2 doses.
The Israeli government announced that it is focusing on the possibility that the falling protection rate of the BioNTech vaccine is due to the Delta variant, which has begun to spread in the country
In Israel, a population of 9.3 million, approximately 60% of the population received at least one dose of BioNTech vaccine
With the decrease in the number of cases, all the measures in the country began to be lifted.
With the effect of the delta variant, the number of cases started to watch over 400 per day.
It has been reported that 42 percent of the patients with the virus in Israel were people who had the Covid-19 vaccine.
Due to the increase in the number of cases, the mask rules were partially reinstated.